Clinical Trial Update: Tocilizumab Real-Life Human Factors (RLHFs) Validation Study [Phase 4]

View source ↗

Summary

Phase 4 study evaluating real-life human factors validation for tocilizumab in rheumatoid arthritis has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2019-04-19